Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.
Marcia S. Brose
Consultant or Advisory Role - Bayer; Onyx
Honoraria - Bayer
Research Funding - Bayer
Christopher Nutting
No relevant relationships to disclose
Barbara Jarzab
Consultant or Advisory Role - AstraZeneca
Rossella Elisei
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Salvatore Siena
Consultant or Advisory Role - Amgen; Bayer; Celgene; Genomic Health; Roche; Sanofi
Lars Bastholt
Consultant or Advisory Role - AstraZeneca
Christelle de la Fouchardiere
No relevant relationships to disclose
Furio Pacini
Honoraria - Bayer
Research Funding - Bayer
Ralf Paschke
No relevant relationships to disclose
Young Kee Shong
No relevant relationships to disclose
Steven I. Sherman
Consultant or Advisory Role - AstraZeneca; Bayer; Eisai; Exelixis; Lilly; Novo Nordisk; Veracyte
Honoraria - AstraZeneca; Bayer; Eisai; Exelixis; Lilly; Novo Nordisk; Veracyte
Research Funding - Genzyme; Pfizer
Johannes WA Smit
Honoraria - Bayer
John Woojune Chung
Employment or Leadership Position - Bayer
Harald Siedentop
Employment or Leadership Position - Bayer
Stock Ownership - Bayer (B)
Istvan Molnar
Employment or Leadership Position - Bayer
Martin Schlumberger
Consultant or Advisory Role - AstraZeneca (U); Bayer (U); Eisai (U); Exelixis (U); Genzyme (U)
Honoraria - AstraZeneca; Genzyme
Research Funding - Genzyme